IGF1 and acromegaly: Regarding clinical and imaging predictors of medical treatment outcome in acromegaly, the most recent data shows, that older age, higher IGF-1 concentration at diagnosis and hypointense T2-weighted MRI signal increase the chance of better response to first-generation SRLs (19).